Fundraising Fox
Cbio
Copenhagen, DK · 1 known investors
Find your way into Cbio
Sign up to see every warm intro you have to Cbio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Cbio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Cbio develops next-generation T-cell therapies for solid tumors, which account for the majority of cancers. Its lead product, novoleucel, is a minimally invasive cell therapy designed to improve clinical outcomes and survival for late-stage cancer patients.
Founders & leadership
JD
Jørgen DamCo-founder & Chief Operating OfficerJørgen Dam has management experience in R&D, manufacturing, and project management within biopharmaceuticals. He is founder of Cbio, which develops next-generation T-cell therapies for solid tumors.
Investors · 1
Frequently asked questions
- What does Cbio do?
- Cbio develops next-generation T-cell therapies for solid tumors, which account for the majority of cancers. Its lead product, novoleucel, is a minimally invasive cell therapy designed to improve clinical outcomes and survival for late-stage cancer patients.
- Who founded Cbio?
- Cbio was founded by Jørgen Dam.
- Who are Cbio's investors?
- Cbio's investors include Elmehøj Ventures.
- Where is Cbio headquartered?
- Cbio is headquartered in Copenhagen, DK.